Abstract
Abstract The feedback control of dCMP deaminase, the first enzyme in a biosynthetic sequence of pyrimidine deoxyribonucleotide interconversions, has been characterized in leukocytes isolated from the peripheral blood of normal subjects and from patients with leukemia. As reported in other systems, dTTP, an end product of the pathway, may function as an allosteric inhibitor of this enzyme, while dCTP, another end product, prevents the dTTP inhibition. Nucleoside deaminase is present in human leukocytes. Some of its properties are described.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
